Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Revenue (2018 - 2025)

Historic Revenue for Serina Therapeutics (SER) over the last 8 years, with Q2 2025 value amounting to $130000.0.

  • Serina Therapeutics' Revenue rose 15490.2% to $130000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $116000.0, marking a year-over-year decrease of 9632.56%. This contributed to the annual value of $56000.0 for FY2024, which is 9822.39% down from last year.
  • Latest data reveals that Serina Therapeutics reported Revenue of $130000.0 as of Q2 2025, which was up 15490.2% from -$14000.0 recorded in Q4 2024.
  • Serina Therapeutics' 5-year Revenue high stood at $3.1 million for Q4 2023, and its period low was -$14000.0 during Q4 2024.
  • For the 5-year period, Serina Therapeutics' Revenue averaged around $206882.4, with its median value being $24000.0 (2021).
  • In the last 5 years, Serina Therapeutics' Revenue soared by 3848750.0% in 2023 and then crashed by 10045.35% in 2024.
  • Over the past 5 years, Serina Therapeutics' Revenue (Quarter) stood at $27000.0 in 2021, then plummeted by 70.37% to $8000.0 in 2022, then soared by 38487.5% to $3.1 million in 2023, then tumbled by 100.45% to -$14000.0 in 2024, then skyrocketed by 1028.57% to $130000.0 in 2025.
  • Its Revenue stands at $130000.0 for Q2 2025, versus -$14000.0 for Q4 2024 and $14000.0 for Q3 2024.